Table 1 of
Iomdina, Mol Vis 2020; 26:623-640. Table 1 of
Iomdina, Mol Vis 2020; 26:623-640.
Table 1. Characteristics of control and POAG groups.
| Parameter | Control | POAG stage | ||||||
|---|---|---|---|---|---|---|---|---|
| IIA | IIB | IIIB | IIIC | IVC | Total | |||
| Number of participants | 9 | 12 | 11 | 21 | 19 | 4 | 67 | |
| Mean age ± SD, years* | 46.55±10.21 | 66.17±8.11 | 66.27±8.22 | 70.00±7.76 | 64.05±9.81 | 72.50±10.34 | 67.16±8.83 | |
| Gender, %** | Male | 55.6 | 76.7 | 45.5 | 38.1 | 47.4 | 50 | 47.8 |
| Female | 44.4 | 33.3 | 54.5 | 61.9 | 52.6 | 50 | 52.2 | |
| IOP ± SD, mmHg | - | 20.0±0.95 | 24.8±2.8 | 25.2±3.1 | 32.1±1.9 | 35.3±3.9 | - | |
| Refraction abnormalities, % | Myopia*** | - | 8.3 | 18.2 | 9.5 | 21.05 | - | 13.4 |
| Hyperopia | - | - | - | - | 10.5 | - | 3.0 | |
| Comorbidities, % | Arterial hypertension | 55.55 | 75.0 | 54.5 | 85.7 | 57.9 | 75.0 | 70.1 |
| Coronary heart disease | 55.55 | 41.7 | 36.4 | 76.2 | 26.3 | 25.0 | 46.3 | |
| Diabetes mellitus | - | - | 18.2 | 14.3 | 10.5 | - | 10.4 | |